col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


26 Ergebisse       Seite 1

 [1] 
Elsevier: Journal of Pharmaceutical and Biomedical Analysis
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Jun―13 Characterization of the tautomeric equilibrium of molnupiravir, an antiviral for the treatment of COVID-19 Samantha A. Burgess, Xiao Wang, Dirk Stueber, Yunyi Wang, Ryan D. Cohen, Yu-hong Lam, et al. (+2)
2 [GO] 2025―Feb―26 An ultra-sensitive, multiplexed, and cost-effective POCT system for the detection of co-infecting respiratory viruses, including SARS-CoV-2, Flu A, Flu B, and RSV, within 30minutes Zhongfu Chen, Lizhen Yan, Jumei Liu, Weilun Zuo, Qunshan Xu, Shan Qiao, et al. (+14)
3 [GO] 2025―Feb―26 Development and validation of an LC-MS/MS method for pharmacokinetic assessment of a bispecific antibody (YBSW015) targeting SARS-CoV-2 Yuan-Yuan Chai, Ling Zhou, Yan Yang, Lin Tan, Ke Ma, Zhi-Jiang Huang
4 [GO] 2024―Dez―16 Plasma metabolomic signatures after oral administration of ritonavir in COVID-19 treatment via chemometrics-assisted UPLC/Q-TOF/MS/MS Fatma Demirkaya Miloglu, Burak Bayrak, Busra Yuksel, Sema Nur Demir, Gulsah Gundogdu, Yucel Kadioglu, A.M. Abd El-Aty
5 [GO] 2024―Mai―29 Potential Usage of Boron Modified Carbon Nanodots as a Marker Candidate for Coronavirus Disease (COVID-19) Antibody Detection Aswandi Wibrianto, Yudha J. Saputra, Siti F.A. Sugito, Siti Q. Khairunisa, Brian E. Rachman, Nasronudin Nasronudin, et al. (+3)
6 [GO] 2024―Apr―09 A Dual-target SPR Screening System for Simultaneous Ligand Discovery of SARS-CoV-2 Spike Protein and Its Receptor ACE2 from Chinese Herbs Ying Zhang, Dongyao Wang, Xiying Wang, Huilin Ma, Yue Liu, Zhanying Hong, et al. (+5)
7 [GO] 2023―Dez―25 Ligand Fishing Approach to Explore Amaryllidaceae Alkaloids as Potential Antiviral Candidates Targeting SARS-CoV-2 Nsp4 Deborah Kimie Yonamine, Vitor Eduardo Narciso dos Reis, Amanda Eiriz Feu, Warley de Souza Borges, Carmen Lucia Cardoso, Taisa Magnani Dinamarco
8 [GO] 2023―Nov―25 Extraction of Covid-19 drug (Favipiravir) from plasma samples by yolk-shell mesoporous silica before HPLC-MS/MS determination Fatemeh Nosratzehi, Parisa Mofatehnia, Mehrnaz Gharagozlou, Mahla Malekzadeh, Mir Ali Farajzadeh, Elnaz Marzi Khosrowshahi, Mohammad Reza Afshar Mogaddam
9 [GO] 2023―Okt―05 Chiral distinction between hydroxychloroquine enantiomers in binding to angiotensin-converting enzyme 2, the forward receptor of SARS-CoV-2 Federica Aiello, Federica Balzano, Gloria Uccello Barretta, Ilaria D’Acquarica, Giulia Mazzoccanti, Israel Agranat
10 [GO] 2023―Sep―19 Separation and Quantification of Azvudine in Plasma of Patients with COVID-19 using LC-MS/MS Zhijun Liu, Fengying Liang, Shouhong Gao, Xiujing Zhu, Xinhua Song, Wansheng Chen, et al. (+3)
11 [GO] 2023―Mrz―29 Biosensing strategies for the detection of SARS-CoV-2 nucleic acids Alejandro Tamborelli, Michael López Mujica, Pablo Gallay, Virginia Vaschetti, Daiana Reartes, Rocío Delpino, et al. (+6)
12 [GO] 2022―Sep―30 A systematic review of the advancement on colorimetric nanobiosensors for SARS-CoV-2 detection Leticia Tessaro, Adriano Aquino, Pedro Panzenhagen, Nirav Joshi, Carlos Adam Conte-Junior
13 [GO] 2022―Sep―26 A highly selective and sensitive competitive aptasensor capable of quantifying thrombin elevated with side effects in severe COVID-19 Jaden Yun, Ji Hoon Lee
14 [GO] 2022―Sep―15 A novel and water-soluble material for coronavirus inactivation from oseltamivir in the cavity of methyl and sulfated-β-cyclodextrins through inclusion complexation Rajaram Rajamohan, Sonaimuthu Mohandoss, Sekar Ashokkumar, Fatiha Madi, Neour Leila, Kuppusamy Murugavel, Yong Rok Lee
15 [GO] 2022―Sep―12 Expediting the chromatographic analysis of COVID-19 antibody therapeutics with ultra-short columns, retention modeling and automated method development Bastiaan Duivelshof, Arnold Zöldhegyi, Davy Guillarme, Matthew Lauber, Szabolcs Fekete
16 [GO] 2022―Mai―10 Untargeted Lipidomics reveals specific lipid profiles in COVID-19 patients with different severity from Campania region (Italy) Michele Ciccarelli, Fabrizio Merciai, Albino Carrizzo, Eduardo Sommella, Paola Di Pietro, Vicky Caponigro, et al. (+21)
17 [GO] 2022―Feb―27 Monitoring of alcohol-based hand rubs in SARS-CoV-2 prevention by HS-GC/MS and electrochemical biosensor: A survey of commercial samples Costanza Majorani, Claudia Leoni, Laura Micheli, Rocco Cancelliere, Marco Famele, Roberta Lavalle, et al. (+5)
18 [GO] 2022―Feb―26 A Stability Indicating RP-HPLC Method for Determination of the COVID-19 Drug Molnupiravir Applied Using Nanoformulations in Permeability Studies Tuba Reçber, Selin Seda Timur, Sevilay Erdoğan, Fatma Yalçın, Tutku Ceren Karabulut, R. Neslihan Gürsoy, et al. (+3)
19 [GO] 2022―Jan―25 Updating the use of nano-biosensors as promising devices for the diagnosis of coronavirus family members: A systematic review Adriano Aquino, Vania Margaret Flosi Paschoalin, Leticia Louize Gonçalves Tessaro, Paulo A. Raymundo-Pereira, Carlos Adam Conte-Junior
20 [GO] 2021―Dez―14 Efficient discovery of potential inhibitors for SARS-CoV-2 3C-like protease from herbal extracts using a native MS-based affinity-selection method Dafu Zhu, Haixia Su, Changqiang Ke, Chunping Tang, Matthias Witt, Ronald J Quinn, et al. (+3)
21 [GO] 2021―Sep―25 Nanostructured sensor platform based on organic polymer conjugated to metallic nanoparticle for the impedimetric detection of SARS-CoV-2 at various stages of viral infection Karen Y.P.S. Avelino, Giselle S. dos Santos, Isaac A.M. Frías, Alberto G. da Silva Júnior, Michelly C. Pereira, Maira G.R. Pitta, et al. (+4)
22 [GO] 2021―Apr―02 A Novel LC-MS/MS Method for Determination of the Potential Antiviral Candidate Favipiravir for the Emergency Treatment of SARS-CoV-2 Virus in Human Plasma; Application to a Bioequivalence Study in Egyptian Human Volunteers Mosaad I. Morsy, Eman G. Nouman, Youmna M. Abdallah, Mourd A. Zainelabdeen, Mohamed M. Darwish, Ahmed Y. Hassan, et al. (+4)
23 [GO] 2021―Jan―28 Simultaneous quantification of seven repurposed COVID-19 drugs remdesivir (plus metabolite GS-441524), chloroquine, hydroxychloroquine, lopinavir, ritonavir, favipiravir and azithromycin by a two-dimensional isotope dilution LC-MS/MS method in human serum Katharina Habler, Mathias Brügel, Daniel Teupser, Uwe Liebchen, Christina Scharf, Ulf Schönermarck, et al. (+2)
24 [GO] 2021―Jan―27 Vitamin C supplementation is necessary for patients with coronavirus disease: an ultra-high-performance liquid chromatography-tandem mass spectrometry finding Yaru Xing, Bing Zhao, Lin Yin, Mingquan Guo, Huichun Shi, Zhaoqin Zhu, et al. (+7)
25 [GO] 2020―Nov―12 Composition analysis of falsified chloroquine phosphate samples seized during the COVID-19 pandemic C.A. Waffo Tchounga, P.Y. Sacre, P. Ciza, R. Ngono, E. Ziemons, Ph. Hubert, R.D. Marini
26 [GO] 2020―Aug―30 QUANTITATIVE MICROSAMPLING FOR BIOANALYTICAL APPLICATIONS RELATED TO THE SARS-CoV-2 PANDEMIC: USEFULNESS, BENEFITS AND PITFALLS Michele Protti, Roberto Mandrioli, Laura Mercolini
 [1] 

26 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.005 sec